AsclepiX Therapeutics

A Biotech Company.

AsclepiX Therapeutics LLC represents the next generation of biologics and drug development technology. They use bioinformatics and systems biology methods to design classes of short biomimetic anti-angiogenic (anti-neovascular) and anti-lymphangiogenic peptides, and They use the latest developments in biomaterials and drug delivery to design long-lasting biodegradable nano- and microparticles to deliver these biomimetic therapeutic peptides throughout the body. We are utilizing our platform technology for indications in ophthalmology, oncology, and for other angiogenesis- and lymphangiogenesis-dependent diseases.